Post Feed

PBS Website Updated: Key Changes from 1 September 2026

01 Sep 2026

The updates include:

Removal of prescriber accreditation requirements for certain hepatitis B and hepatitis C medicines under the PBS Highly Specialised Drugs Program.
New recommendations from the May 2026 PBAC Intracycle Meeting.
Changes to PBS Schedule PDFs to improve accessibility and efficiency.
Updates to Active Ingredient Prescribing information.
Updated information on Section 19A medicines subsidised under the PBS.
Updated ex-manufacturer price information.
Changes to the Medicine Status Website.
Updated requirements and information covering minimum stockholding, designated brands and the Medicines Supply Security Guarantee.
Changes to PBAC submission deadlines for item delisting in 2027.
The September 2026 PBAC meeting agenda has been released.
Updates on pharmacy practice, including dispensing guidelines and governance.
Further information on the rapid review of PBS medicines for relapsing-remitting multiple sclerosis.
Updated PBS subsidy arrangements for dapsone tablets supplied under the Special Supply Scheme.
Information on monitoring final overall survival results for cancer medicines.

The latest Schedule of Pharmaceutical Benefits and full list of changes are available through the PBS website.

PBS Website Updated: Key Changes from 1 September 2026

Source: Pharmaceutical Benefits Scheme (PBS), Australian Government — PBS Website Update

PBS Website Updated: Key Changes from 1 September 2026